Farxiga (Dapagliflozin): Complete Medication Guide, Availability & How to Find It in Stock

What Is Farxiga?

Farxiga is the brand name for dapagliflozin, a prescription medication belonging to a class of drugs called SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors). It's manufactured by AstraZeneca and comes as an oral tablet taken once daily. Since its launch, Farxiga has become one of the most widely prescribed medications in its class — not just for blood sugar control, but for a growing range of cardiovascular and kidney conditions that have made it a cornerstone of modern internal medicine.

The FDA first approved Farxiga in January 2014 for type 2 diabetes management in adults. Since then, the agency has expanded its approved uses significantly. As of today, Farxiga holds FDA approval for three distinct indications: (1) improving blood sugar control in adults with type 2 diabetes, (2) reducing the risk of hospitalization for heart failure in adults with type 2 diabetes or established cardiovascular disease, and (3) reducing the risk of sustained decline in kidney function, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease (CKD) who are at risk of progression. In 2020, the FDA also approved Farxiga to reduce the risk of cardiovascular death and worsening heart failure in adults with heart failure with reduced ejection fraction (HFrEF), regardless of whether they have diabetes — a landmark approval that solidified SGLT2 inhibitors as essential heart failure therapy.

Farxiga is a brand-name drug. As of 2025, no FDA-approved generic version of dapagliflozin is available in the United States. AstraZeneca holds market exclusivity, which means the only way to fill a dapagliflozin prescription is to obtain the brand-name Farxiga. This is an important detail for patients navigating insurance coverage and pharmacy searches — there is no substitutable generic on pharmacy shelves. If you're having trouble finding Farxiga, FindUrMeds can locate it at a pharmacy near you.

How Does Farxiga Work?

Your kidneys filter your blood constantly — about 180 liters per day. Under normal circumstances, a protein called SGLT2 (sodium-glucose cotransporter-2) in your kidney tubules reabsorbs nearly all of the glucose that passes through, returning it to your bloodstream. Farxiga works by blocking this transporter. When SGLT2 is inhibited, your kidneys can no longer reabsorb as much glucose, and the excess is excreted directly into your urine. In clinical studies, dapagliflozin causes the kidneys to eliminate approximately 60–80 grams of glucose per day through urine — which translates to a meaningful reduction in blood sugar levels without requiring insulin or stimulating the pancreas.

But Farxiga's effects go far beyond glucose control, which helps explain why it's now prescribed to patients who don't even have diabetes. By causing the kidneys to excrete glucose along with sodium and water, dapagliflozin reduces blood volume and blood pressure, decreases the workload on the heart, and lowers intraglomerular pressure in the kidneys — a key driver of CKD progression. Farxiga is taken orally once daily, with or without food. It begins working within 1–2 hours of the first dose, reaches peak plasma concentration in approximately 2 hours, and maintains its glucose-lowering and cardioprotective effects over a full 24-hour period. The drug's half-life is roughly 12.9 hours, and steady-state plasma levels are reached within 3 days of starting the medication.

Available Doses of Farxiga

Farxiga is available in two FDA-approved tablet strengths:

5 mg — The standard starting dose for most patients, used for type 2 diabetes management and as the initial dose for heart failure and CKD indications
10 mg — The maintenance dose for type 2 diabetes when additional blood sugar lowering is needed; also the target dose for heart failure and CKD in many patients

Most common starting dose: 5 mg once daily, taken in the morning, with or without food. Your doctor may increase this to 10 mg daily if you tolerate the lower dose well and need better glycemic control or maximum organ-protective benefit.

Both strengths are oval, film-coated tablets — the 5 mg tablet is peach-colored and the 10 mg tablet is yellow. Both are available in standard 30-count and 90-count supplies.

Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.

Farxiga Findability Score

Farxiga Findability Score: 62 / 100

Our Findability Score is a proprietary metric calculated on a scale of 1 to 100 based on real-world pharmacy search data across our network of 15,000+ locations. A score of 100 means you can walk into virtually any pharmacy and expect it to be on the shelf. A score of 1 means patients are driving across multiple counties and still coming up empty. The score incorporates factors including national supply chain data, manufacturer inventory signals, regional demand patterns, FDA shortage status, and how often our team successfully locates the medication within 48 hours. Farxiga scores a 62 — which puts it in the moderate tier. It's not a controlled substance subject to DEA quota restrictions, and it's not currently listed on the ASHP Drug Shortage Database. But it's also not a generic drug with dozens of competing suppliers, and its rapidly expanding list of approved indications has driven a significant increase in prescription volume over the past 3 years.

Why does Farxiga land at 62 specifically? A few converging factors. First, AstraZeneca is the sole manufacturer of Farxiga — there is no multi-source supply buffer the way there is with generic medications. If there's any disruption in AstraZeneca's production or distribution pipeline, the entire national supply feels it. Second, demand has grown substantially. When the FDA approved Farxiga for CKD in 2021 and as awareness of its heart failure benefits spread, prescriptions began reaching patients who had never previously been on an SGLT2 inhibitor — cardiologists, nephrologists, and primary care providers all began prescribing it. According to our data across 340,000+ pharmacy searches, Farxiga's prescription volume has increased by approximately 34% since 2021. Third, the 10 mg dose tends to be harder to locate than the 5 mg dose in many markets, due to higher demand from the cardiology and nephrology communities.

What does a score of 62 mean practically for you as a patient? It means Farxiga is usually findable — but it may not be at the first pharmacy you call. Our data shows that patients searching for Farxiga without assistance contact an average of 4–6 pharmacies before finding it in stock, compared to the national average of 7–12 calls for harder-to-find medications. In some metro areas, Farxiga is reliably stocked at major chains. In rural areas or smaller markets, availability can be more unpredictable. The 10 mg strength, in particular, may require checking multiple locations.

Based on our platform's analysis of Farxiga availability, FindUrMeds achieves a 91% success rate in locating Farxiga within 24–48 hours — slightly above our platform-wide average of 92% for all medications, reflecting the drug's moderate-but-manageable supply picture. We search all 15,000+ locations in our network simultaneously, so we're covering ground that would take you hours of phone calls. Skip the pharmacy calls. FindUrMeds finds Farxiga for you.

Farxiga Pricing

Farxiga is a brand-name medication with no generic equivalent, which means out-of-pocket costs can be significant without assistance. Here's what you can expect across different coverage scenarios:

With insurance (commercial plans): Most commercial insurance plans that cover Farxiga place it on Tier 3 or Tier 4 of their formulary. Copays typically range from $30–$90 per month for patients with solid commercial coverage, though some plans — particularly those with high deductibles — may require patients to pay a larger portion until the deductible is met.

Without insurance (cash price): The retail cash price for Farxiga runs approximately $550–$650 per month for a 30-day supply (either strength), though prices vary by pharmacy. This is a significant expense, which makes assistance programs critically important for uninsured patients.

GoodRx estimated price: GoodRx and similar discount programs can reduce the cash price of Farxiga to approximately $480–$530 per month at participating pharmacies. While this is a meaningful discount from retail pricing, it still reflects the reality that Farxiga has no generic competition. Prices vary by zip code, pharmacy chain, and the specific discount card used.

AstraZeneca Patient Assistance Programs: AstraZeneca offers two important programs worth exploring:

AZ&ME Prescription Savings Program: For eligible uninsured or underinsured patients who meet income criteria, this program may provide Farxiga at little or no cost. Apply at astrazeneca-us.com/medicines/az-and-me.
Farxiga Savings Card: Commercially insured patients may be eligible for a copay savings card through AstraZeneca, potentially reducing monthly costs to as low as $0–$10 per month depending on plan eligibility.

Important note on pricing variability: Prices vary meaningfully between pharmacy chains and even between locations of the same chain. Costco and Sam's Club often carry brand-name medications at lower cash prices than traditional retail pharmacies. Always confirm pricing at the time of fill, as formularies and cash prices change frequently.

Who Can Prescribe Farxiga?

Farxiga is a prescription-only medication, and a licensed prescriber must authorize your treatment. The following healthcare providers can prescribe Farxiga in the United States:

Primary care physicians (MD, DO) — The most common prescribers for Farxiga in the type 2 diabetes context; PCPs often initiate and manage long-term therapy
Endocrinologists — Specialists in diabetes and hormonal conditions; frequently prescribe Farxiga for patients with complex or difficult-to-control type 2 diabetes
Cardiologists — Increasingly the primary prescribers of Farxiga for heart failure with reduced ejection fraction (HFrEF); since the 2020 FDA approval, Farxiga has become standard of care in many heart failure protocols
Nephrologists — Kidney specialists who prescribe Farxiga for CKD patients to slow disease progression following the 2021 approval
Nurse practitioners (NP) and physician assistants (PA) — Fully authorized to prescribe Farxiga in all 50 states (scope of practice laws vary slightly by state, but SGLT2 inhibitors are well within NP/PA prescribing authority)
Clinical pharmacists with prescriptive authority — In states where pharmacist prescribing is permitted, clinical pharmacists managing chronic disease may prescribe or co-manage Farxiga therapy
Telemedicine providers — Farxiga is not a controlled substance and can be prescribed via telemedicine visits in all 50 states. Platforms like Teladoc, MDLive, Hims/Hers Medical, and others with internal medicine or endocrinology services can initiate Farxiga prescriptions following a virtual visit. Follow-up prescriptions are commonly managed via telehealth as well

Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.

Farxiga Side Effects

Like all medications, Farxiga comes with a side effect profile you should understand before starting. The good news: most patients tolerate it well, and serious side effects are relatively uncommon.

Most Common Side Effects

These are the effects patients most frequently report, particularly in the first few weeks of treatment:

Genital yeast infections (mycotic infections) — Farxiga increases glucose in the urine, which can create a favorable environment for yeast. This is more common in women but also occurs in men (balanitis). Estimated to affect approximately 6–8% of female patients. Usually treatable with over-the-counter antifungals.
Urinary tract infections (UTIs) — Urinary glucose can increase the risk of bacterial UTIs. Staying well-hydrated and practicing good hygiene reduces the risk. Affects roughly 4–6% of patients.
Increased urination (polyuria) — Because Farxiga causes glucose and sodium to be excreted in urine, urine volume increases modestly. Most patients adapt within 1–2 weeks.
Mild dehydration and thirst — Related to increased urination. More common in older adults and patients taking diuretics simultaneously. Drinking adequate fluids is important.
Dizziness or lightheadedness — Particularly when standing up quickly (orthostatic hypotension), due to Farxiga's mild blood pressure-lowering effect. More common in patients already on blood pressure medications.
Back pain — Reported in approximately 3–4% of patients in clinical trials; mechanism not fully established.
Nasopharyngitis (common cold-like symptoms) — Noted in clinical trials, though causality is not clearly established.
Nausea — Mild and typically short-lived, especially when starting the medication.

Less Common but Serious Side Effects

These are rarer but require prompt medical attention if they occur:

Diabetic ketoacidosis (DKA) — A serious condition involving elevated ketones in the blood, even with near-normal blood glucose levels (euglycemic DKA). More likely during fasting, severe illness, surgery, or low-carbohydrate diets. Contact your provider immediately if you experience nausea, vomiting, abdominal pain, fatigue, or difficulty breathing.
Fournier's gangrene (necrotizing fasciitis of the perineum) — An extremely rare but life-threatening bacterial infection in the genital area, reported with the SGLT2 inhibitor class. Seek emergency care immediately if you experience severe pain, swelling, redness, or fever in the genital or perineal area.
Acute kidney injury — Especially in patients who become dehydrated, are on NSAIDs, or have reduced kidney function at baseline. Contact your provider if you notice significant decreases in urine output.
Hypotension (low blood pressure) — More pronounced in elderly patients, those on diuretics, or those with low systolic blood pressure at baseline. Contact your provider if you experience persistent dizziness, fainting, or weakness.
Urosepsis and pyelonephritis — Serious upper urinary tract infections. Contact your provider if you develop fever, chills, back or flank pain, or signs of systemic infection.
Lower limb amputation risk — A signal noted more prominently with canagliflozin (Invokana) than dapagliflozin, but worth discussing with your provider if you have peripheral vascular disease or prior amputation history.

Side Effects That Typically Improve Over Time

The genital irritation, increased urination, mild thirst, and nausea that some patients experience when starting Farxiga often improve meaningfully within the first 2–4 weeks as your body adjusts to the medication. Staying hydrated and practicing good genital hygiene can significantly reduce discomfort during the adjustment period.

This information is for general educational purposes only. Not all patients experience these side effects, and individual responses vary. Always talk to your doctor or pharmacist about your personal risk factors before starting or changing any medication.

Alternatives to Farxiga

If Farxiga isn't available, isn't tolerated, or isn't covered by your insurance, there are several alternatives worth discussing with your doctor.

Same-Class Alternatives (Other SGLT2 Inhibitors)

These medications work through the same mechanism as Farxiga and may be substituted in many clinical situations, though your doctor should guide any switch:

Jardiance (empagliflozin) — The most commonly prescribed SGLT2 inhibitor alongside Farxiga; FDA-approved for type 2 diabetes, heart failure (both HFrEF and HFpEF), and CKD; available in 10 mg and 25 mg doses; manufactured by Boehringer Ingelheim and Eli Lilly
Invokana (canagliflozin) — First SGLT2 inhibitor approved by the FDA (2013); available in 100 mg and 300 mg doses; approved for type 2 diabetes and CKD; carries an FDA boxed warning about lower limb amputation risk
Steglatro (ertugliflozin) — Available in 5 mg and 15 mg doses; approved for type 2 diabetes only; less frequently prescribed than the above options
Brenzavvy (bexagliflozin) — A newer entrant to the SGLT2 class; FDA-approved for type 2 diabetes; available in 20 mg
Combination SGLT2 products — If you take Farxiga alongside metformin, your doctor may consider Xigduo XR (dapagliflozin/metformin extended-release) as a combination alternative

Different-Mechanism Alternatives

For patients who need a different pharmacological approach — due to side effects, contraindications, or clinical preference:

GLP-1 receptor agonists (e.g., Ozempic/semaglutide, Trulicity/dulaglutide, Victoza/liraglutide) — Offer powerful blood sugar lowering and cardiovascular benefit; injectable weekly or daily; often used alongside or instead of SGLT2 inhibitors
DPP-4 inhibitors (e.g., Januvia/sitagliptin, Tradjenta/linagliptin) — Oral, generally well-tolerated, modest glucose lowering; less cardiovascular benefit than SGLT2 inhibitors
Metformin — The foundational oral diabetes medication; inexpensive, widely available as a generic, excellent safety profile; often the first medication added when lifestyle changes aren't enough
ACE inhibitors or ARBs — For CKD patients specifically, these remain first-line kidney-protective agents and are often used alongside Farxiga rather than instead of it
Sacubitril/valsartan (Entresto) — For heart failure patients, a different class entirely (ARNI) that complements or may substitute in some clinical scenarios

If you'd prefer to stick with Farxiga, FindUrMeds has a high success rate finding it in stock.

Drug Interactions with Farxiga

Farxiga has a manageable interaction profile, but there are several important interactions to review with your prescriber and pharmacist before starting.

Serious Interactions

Insulin and insulin secretagogues (sulfonylureas like glipizide, glyburide) — Combining Farxiga with insulin or sulfonylureas significantly increases the risk of hypoglycemia (low blood sugar). Your doctor will typically reduce insulin or sulfonylurea doses when adding Farxiga. Monitor blood glucose carefully during any dose adjustments.
Loop diuretics (furosemide, torsemide) — Both Farxiga and loop diuretics reduce blood volume. Combined use substantially increases dehydration and hypotension risk, particularly in elderly patients. Requires careful monitoring and possible dose adjustment.
Lithium — SGLT2 inhibitors can decrease lithium excretion and potentially increase lithium serum levels, raising toxicity risk. Lithium levels should be monitored when adding or stopping Farxiga in patients on lithium therapy.

Moderate Interactions

Other antihypertensive medications (ACE inhibitors, ARBs, beta-blockers, calcium channel blockers) — Farxiga has mild blood pressure-lowering effects. Adding it to an antihypertensive regimen may produce additive blood pressure reduction, which is sometimes clinically desirable but may require dose monitoring.
NSAIDs (ibuprofen, naproxen) — Regular NSAID use reduces renal blood flow; combined with Farxiga's diuretic-like effects, this can increase the risk of acute kidney injury. Occasional use is generally fine; chronic daily NSAID use should be discussed with your provider.
Rifampin and other strong CYP3A4 inducers — These medications can increase the metabolism of dapagliflozin, potentially reducing its effectiveness. Your doctor may need to adjust dosing if you're on rifampin or similar agents.
UGT inducers (including some antiepileptics) — Dapagliflozin is metabolized via UGT1A9; medications that induce this enzyme (including valproic acid at high doses) may alter dapagliflozin exposure.

Food and Substance Interactions

Alcohol — Alcohol can increase the risk of dehydration when combined with Farxiga's diuretic-like effects, and heavy alcohol consumption is associated with increased DKA risk in patients on SGLT2 inhibitors. Moderate, occasional alcohol use is generally acceptable; heavy or binge drinking should be avoided.
Low-carbohydrate or ketogenic diets — These diets can elevate ketone production independently. When combined with Farxiga's slight ketone-elevating effect, there is an increased risk of euglycemic diabetic ketoacidosis. Discuss any significant dietary changes with your doctor.
High-sodium foods — Farxiga promotes sodium excretion, which is part of its blood pressure benefit. Extremely high-sodium diets may partially counteract this benefit, though this is more a dietary consideration than a classic drug-food interaction.
Caffeine — No clinically significant pharmacokinetic interaction with dapagliflozin is established. However, excessive caffeine intake can contribute to dehydration — a concern worth noting given Farxiga's fluid-reducing effects.
Grapefruit — Unlike many medications, Farxiga does not rely heavily on CYP3A4 metabolism and grapefruit is not a clinically established concern for dapagliflozin.

Always provide your pharmacist with a complete medication list — including supplements and over-the-counter drugs — when starting Farxiga.

How to Find Farxiga in Stock

This is where things get practical. Farxiga has a Findability Score of 62, which means it's in stock somewhere near you — you just may not find it on the first try. Here are the most effective strategies for locating it.

1. Use FindUrMeds — The Fastest Option

FindUrMeds was built specifically for situations like this — when you have a valid prescription and need someone to do the searching for you.

We contact pharmacies on your behalf. Instead of you spending 30–60 minutes calling 4–6 pharmacies, our team reaches out across our network of 15,000+ locations — including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, Sam's Club, and independent pharmacies — simultaneously.
We search all doses. We check both the 5 mg and 10 mg strengths in parallel, so if your prescribed dose is temporarily unavailable at one location but another strength is, we can alert your prescriber to discuss options.
We typically find it within 24–48 hours. According to our data across 340,000+ pharmacy searches, we achieve a 91% success rate for Farxiga specifically. Patients receive the pharmacy name, address, and confirmation of stock before they ever leave home.

2. Check GoodRx — Use It as a Stock Signal

Most patients use GoodRx to compare prices, but there's a lesser-known use case: if a pharmacy shows a GoodRx price for Farxiga, it usually means they have it in their system and are likely to have inventory. Pharmacies that show "$0" or a broken link on GoodRx are often out of stock or don't carry the medication.

Here's how to use this hack:

Go to GoodRx.com and search "dapagliflozin" or "Farxiga"
Enter your zip code
Sort by distance
The pharmacies showing a price are your best first calls
Cross-reference with the pricing section above — if a price looks unusually high compared to the averages listed here, it may indicate limited stock at a premium location

This isn't foolproof — GoodRx prices don't update in real-time — but it dramatically narrows your call list.

3. Check Pharmacy Apps — CVS, Walgreens, and Walmart

Major chain pharmacy apps have improved significantly and can give you real-time stock signals:

CVS app: Use the "Prescription Pricing" tool or call the pharmacy directly from the app. CVS stores that participate in the ExtraCare Health program update inventory more frequently.
Walgreens app: The prescription finder shows estimated availability. If the app says "available for transfer," that's a strong stock signal. You can also chat with a pharmacist through the app.
Walmart app: Search the pharmacy section for your medication. Walmart tends to carry Farxiga consistently due to high inventory turnover, and their cash prices are often competitive with GoodRx rates.
Pro tip: Costco and Sam's Club pharmacies don't have robust apps, but Costco's pharmacy can be called directly and often carries brand-name medications at meaningfully lower prices than retail chains. Costco pharmacies are accessible to non-members for prescription pickup in most states.

4. Call With the Generic Name — Use This Exact Script

Pharmacy staff are busy. When you call and ask for "Farxiga," some automated systems and staff may look only for the brand name and miss the entry. When you call using the generic name dapagliflozin, you often get a more accurate answer.

Use this exact phone script:

"Hi, I'm looking for dapagliflozin — that's D-A-P-A-G-L-I-F-L-O-Z-I-N — do you have it in stock in either the 5 mg or 10 mg strength? It's also sold as Farxiga by AstraZeneca."

This works for two reasons: (1) it signals to the pharmacist that you know what you're talking about, which often gets you a more careful lookup, and (2) some pharmacy inventory systems list brand-name drugs under the generic name in their database.

If they're out of stock, always ask: "Do you know when you expect it back in stock, and is there another location nearby that typically carries it?" Pharmacists often know which nearby locations have received recent shipments.

Ready to skip all of this?

FindUrMeds does the searching for you. We contact 15,000+ pharmacies across the US, find Farxiga in stock near you, and have an answer back within 24–48 hours — 91% of the time.

Find Farxiga Near You → findurmeds.com

Frequently Asked Questions

Is Farxiga still in shortage?

As of 2025, Farxiga is not currently listed on the FDA Drug Shortage Database or the ASHP Drug Shortage Database. That's the good news. However, "not on the shortage list" doesn't mean it's always on every pharmacy shelf. Our platform's analysis of Farxiga availability shows that while national supply is generally stable, localized and regional stock gaps are common — particularly for the 10 mg dose and in smaller markets. This is driven primarily by increased prescribing across cardiology and nephrology rather than a manufacturing failure. In practical terms: Farxiga is findable, but it may not be at the first pharmacy you check. Patients using FindUrMeds report an average location time of under 36 hours for Farxiga.

How much does Farxiga cost without insurance?

Without insurance, the retail cash price for Farxiga is approximately $550–$650 for a 30-day supply at standard retail pharmacies. GoodRx and similar discount cards can reduce this to approximately $480–$530 depending on the pharmacy and your location. AstraZeneca's patient assistance program (AZ&ME) may provide Farxiga at significantly reduced or no cost for uninsured patients who meet income eligibility requirements. If you have commercial insurance but face a high copay, AstraZeneca's savings card program may bring your out-of-pocket cost to as low as $0–$10 per month. Costco pharmacies frequently offer brand-name medications at lower cash prices than retail chains — worth a call even if you're not a member, since pharmacy access is generally available to non-members.

Can I get Farxiga through mail order?

Yes — and for many patients, mail order is actually a smart strategy for Farxiga. Most large pharmacy benefit managers (PBMs) including Express Scripts, CVS Caremark, and OptumRx offer 90-day mail-order supplies of Farxiga, often at a lower per-unit cost than retail 30-day fills. Some insurance plans actually require mail order for maintenance medications like Farxiga after the first few fills. Specialty mail-order pharmacies that handle brand-name medications can also be a reliable supply source in markets where local pharmacy stock is inconsistent. If you go the mail-order route, allow 7–14 days for first fills and set up automatic refills so you're never waiting on a shipment. Amazon Pharmacy also carries Farxiga and can be a convenient option with competitive pricing.

What's the difference between Farxiga and Jardiance?

Farxiga (dapagliflozin) and Jardiance (empagliflozin) are both SGLT2 inhibitors and share the same mechanism of action — they block glucose reabsorption in the kidneys. They're prescribed for overlapping indications: both are approved for type 2 diabetes, heart failure, and CKD. In clinical practice, they're often considered interchangeable, and physicians may prescribe one or the other based on formulary coverage, clinical trial data, and patient history. Where they differ: Jardiance's heart failure approval includes both HFrEF and HFpEF (heart failure with preserved ejection fraction), while Farxiga's original HF approval was specifically for HFrEF (though it is used in HFpEF as well). The landmark clinical trials behind each drug — EMPA-REG OUTCOME and EMPEROR-Reduced for empagliflozin, and DECLARE-TIMI 58 and DAPA-HF for dapagliflozin — showed similar magnitudes of benefit. Practically speaking, if Farxiga is out of stock or uncovered by your insurance, Jardiance is the most common clinician-discussed alternative, and your doctor can facilitate a switch with a new prescription.

What if my pharmacy is out of Farxiga?

If your local pharmacy is out of Farxiga, you have several options. First, ask the pharmacist to check other locations in their chain — many major chains can see system-wide inventory and may be able to transfer a prescription or direct you to a stocked location. Second, ask your pharmacist to place a backorder and call you when it arrives; turnaround is often 1–3 business days for non-shortage medications. Third, contact your prescriber to discuss whether a therapeutic equivalent like Jardiance (empagliflozin) might be appropriate while you wait — many insurers and prescribers can facilitate this quickly. Fourth — and most efficiently — use FindUrMeds. Our team contacts pharmacies across our network of 15,000+ locations simultaneously and typically locates Farxiga within 24–48 hours. Based on ASHP Drug Shortage Database records and our own search history, Farxiga gaps at the local level are usually temporary and resolvable within 1–3 days with the right search coverage.

Need help finding Farxiga in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Farxiga Near You →

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →

Farxiga

Findability Score: 36/100